EP Patent

EP1518575B1 — Medical automatic medicator

Assigned to Panasonic Corp · Expires 2010-11-24 · 15y expired

What this patent protects

After part of the cladding of a medicator main body has been abutted against a medication region, an injection syringe needle received in the main body is automatically projected for jabbing the needle into the medication region and on the other hand, the injection syringe needle…

USPTO Abstract

After part of the cladding of a medicator main body has been abutted against a medication region, an injection syringe needle received in the main body is automatically projected for jabbing the needle into the medication region and on the other hand, the injection syringe needle jabbed into the medication region is automatically received back in the medicator main body, thereby effecting needle removal from the medication region. This reduces the pain which is felt by the patient during the jabbing and removal of the needle, and makes it possible to effect medication at a given speed during a medicinal liquid extraction and to effect easy and reliable mixing even when a two-liquid type or melt-mixing type medicinal liquid is used.

Drugs covered by this patent

Patent Metadata

Patent number
EP1518575B1
Jurisdiction
EP
Classification
Expires
2010-11-24
Drug substance claim
No
Drug product claim
No
Assignee
Panasonic Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.